Morris S L, Mackall J C, Malik A, Rouse D A, Chaparas S D
Center for Biologics Evaluation and Research, Food and Drug Administration Bethesda, Maryland 20892.
Tuber Lung Dis. 1992 Jun;73(3):129-33. doi: 10.1016/0962-8479(92)90144-9.
The immunoreactivity of four recombinant Mycobacterium intracellulare beta-galactosidase fusion proteins, which correspond to 22, 40, 43 and 85 kDa M. intracellulare antigens, was assessed. Lymphoproliferative assays demonstrated that Escherichia coli lysates containing each of the fusion proteins stimulated T cells in vitro. Purified preparations of three of these recombinant M. intracellulare antigens (22, 43 and 85 kDa) also induced delayed-type hypersensitivity (DTH) reactions in sensitized guinea pigs. However, the skin test responses evoked by each of these antigens was not species-specific. Given these results, the potential utility as skin test reagents of the purified antigens or peptides derived from these proteins is discussed.
对四种重组胞内分枝杆菌β-半乳糖苷酶融合蛋白的免疫反应性进行了评估,这四种融合蛋白分别对应于22、40、43和85 kDa的胞内分枝杆菌抗原。淋巴细胞增殖试验表明,含有每种融合蛋白的大肠杆菌裂解物在体外刺激T细胞。其中三种重组胞内分枝杆菌抗原(22、43和85 kDa)的纯化制剂在致敏豚鼠中也诱导了迟发型超敏反应(DTH)。然而,这些抗原所引发的皮肤试验反应并非种属特异性的。基于这些结果,讨论了这些纯化抗原或源自这些蛋白的肽作为皮肤试验试剂的潜在用途。